Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis-Reference-Cited by-同舟云学术

Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis

Published:2021-01 Issue: Volume:209 Page:112921
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Bellet Marina M.,Borghi Monica^ORCID,Pariano Marilena,Renga Giorgia,Stincardini Claudia^ORCID,D’Onofrio Fiorella,Brancorsini Stefano^ORCID,Garaci Enrico,Costantini Claudio^ORCID,Romani Luigina

Funder

Fondazione per la Ricerca sulla Fibrosi Cistica

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference42 articles.

1. The future of cystic fibrosis care: a global perspective;Bell;Lancet Respir Med,2020

2. Cystic fibrosis;Elborn;Lancet,2016

3. Pathogenesis of fungal infections in cystic fibrosis;Williams;Curr Fungal Infect Rep,2016

4. Cystic fibrosis: emerging understanding and therapies;Rey;Annu. Rev. Med.,2019

5. Cystic fibrosis from the gastroenterologist’s perspective;Ooi;Nat. Rev. Gastroenterol. Hepatol.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic drug discovery: a case for thymosin alpha-1;Frontiers in Medicine;2024-06-06

2. The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2;Immunity & Ageing;2023-07-05

3. COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections;International Immunopharmacology;2023-04

4. Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches;International Journal of Molecular Sciences;2021-02-16